We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Pacemakers Undo Valve Replacement Benefits

By HospiMedica International staff writers
Posted on 29 Dec 2011
Right ventricle pacing may undermine the benefits of transcatheter aortic-valve replacement (TAVI), according to a new study.

Researchers at the University of Bonn (Germany) conducted a prospective study involving 86 consecutive patients between 2008 and 2010 (38 male; mean age 80), with severe symptomatic aortic-valve stenosis and indication for TAVI. More...
Of these, 29 Patients (34%) had already had a pacemaker placed before TAVI, or needed one due to post-interventional AV-Block III. The study was designed to evaluate the effects of right ventricular pacing on left ventricular function after TAVI; follow up was after six months with echocardiography.

The results showed that left ventricular Tei-Index (LC-Tei) and systolic pulmonal-artery pressure, as well as left ventricular mass index and right ventricular indices, did not differ before TAVI in both groups. However, six months after TAVI left ventricular ejection fraction increased significantly in the group without permanent pacemaker, and was significantly different to the ejection fraction of the pacemaker group six months after TAVI. Systolic pulmonary artery pressure (sPAP), as well as LV-Tei were different between both groups after six months, but failed to show statistical significance. Left ventricular mass index and right ventricular indices did not differ before and six months after TAVI in both groups. The study was presented at EuroEcho 2011, held during December 2011 in Budapest (Hungary).

“If they need a pacemaker, they need it; and if they do not get the TAVI, they would probably die within one or two years. They need both,” said lead author and study presenter Marcel Weber, MD, and colleagues of the department of cardiology. “We have to watch the ejection fraction; if they don't get a better ejection fraction three months after TAVI then we have to consider a different device, a cardiac resynchronization device.”

TAVI involves the percutaneous insertion of a catheter containing a replacement valve at a site in the groin or the left chest. The new valve is pushed into the correct site, where the surgeon expands it and pushes the old one aside. The procedure is much less invasive than traditional open heart aortic valve replacement and does not require putting the patient on a heart and lung machine, so it can be performed on those who cannot have open heart surgery. In addition, data from recent trials suggest that this procedure might also be a viable option for patients who qualify for open-heart surgery, but who are considered high-risk surgical candidates.

Related Links:

University of Bonn




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.